| 今开：9.94 | 昨收：10.04 |
| 最高：10.28 | 最低：9.935 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：7.07162047E8 |
chuminhua2022-06-11 11:42
6月10日，Cogent Biosciences 的股价上涨了 78%，此前该公司报告了强效、选择性 KIT D816V 抑制剂bezuclastinib用于晚期系统性肥大细胞增多症患者中治疗的 II 期试验的“积极”初步数据。
截至 5 月 24 日的数据截止日期，该开放标签试验已经在四个剂量水平中的1个治疗了 11 名患者。两名患者...查看全文
Cogent Biosciences(COGT)03-14 20:27
$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-23-007717 Act: 34 Size: 496 KB 网页链接查看全文
Cogent Biosciences(COGT)03-15 04:06
$Cogent Biosciences(COGT)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-23-070121 Act: 33 Size: 83 KB 网页链接查看全文
Cogent Biosciences(COGT)03-14 21:12
$Cogent Biosciences(COGT)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-23-007729 Act: 34 Size: 14 MB 网页链接查看全文
Cogent Biosciences(COGT)02-15 06:03
$Cogent Biosciences(COGT)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-23-021868 Act: 34 Size: 265 KB 网页链接查看全文
Cogent Biosciences(COGT)02-16 04:57
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-005141 Size: 9 KB 网页链接查看全文
Cogent Biosciences(COGT)02-16 04:57
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-005137 Size: 9 KB 网页链接查看全文
Cogent Biosciences(COGT)02-16 04:51
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-005135 Size: 9 KB 网页链接查看全文
Cogent Biosciences(COGT)02-15 05:57
$Cogent Biosciences(COGT)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-23-021816 Act: 34 Size: 79 KB 网页链接查看全文
Cogent Biosciences(COGT)02-15 03:27
$Cogent Biosciences(COGT)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001214659-23-002279 Act: 34 Size: 81 KB 网页链接查看全文
Cogent Biosciences(COGT)03-15 04:06
$Cogent Biosciences(COGT)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-23-070121 Act: 33 Size: 83 KB 网页链接查看全文
Cogent Biosciences(COGT)03-14 21:12
$Cogent Biosciences(COGT)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-23-007729 Act: 34 Size: 14 MB 网页链接查看全文
Cogent Biosciences(COGT)03-14 20:27
$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-23-007717 Act: 34 Size: 496 KB 网页链接查看全文
Cogent Biosciences(COGT)02-16 04:57
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-005137 Size: 9 KB 网页链接查看全文
Cogent Biosciences(COGT)02-16 04:57
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-005138 Size: 9 KB 网页链接查看全文
Cogent Biosciences(COGT)02-16 04:57
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-005140 Size: 5 KB 网页链接查看全文
Cogent Biosciences(COGT)02-16 04:57
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-005141 Size: 9 KB 网页链接查看全文
Cogent Biosciences(COGT)02-16 04:51
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-005135 Size: 9 KB 网页链接查看全文
Cogent Biosciences(COGT)02-15 06:03
$Cogent Biosciences(COGT)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-23-021868 Act: 34 Size: 265 KB 网页链接查看全文
Cogent Biosciences(COGT)02-15 05:57
$Cogent Biosciences(COGT)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-23-021816 Act: 34 Size: 79 KB 网页链接查看全文
Cogent Biosciences(COGT)宣布已开始承销公开发行1.25亿美元的普通股。Cogent打算将此次发行的净收益用于与bezuclastinib和其他候选产品相关的开发、监管和商业准备活动，以及营运资金和一般公司用途。Jefferies、Piper Sandler& Co.和Gugge... 网页链接
$Cogent(COGT)$ 内部交易: 2017-03-14,COO,Jordan Harry Baker III ,买入,40000普通股, $3.60
$Cogent(COGT)$ 美东时间 2017-03-09 盘后 披露财报，预期EPS -0.1 网页链接
$Cogent(COGT)$ 内部交易: 2017-01-26,CEO of Fluent, LLC,Schulke Ryan ,买入,15000普通股, $3.95
$Cogent(COGT)$ 内部交易: 2017-01-20,Director,Swayman Robert ,买入,50000普通股, $3.12
$Cogent(COGT)$ 内部交易: 2017-01-23,总裁 of Fluent, LLC,Conlin Matthew ,买入,100000普通股, $3.15
$Cogent(COGT)$ 内部交易: 2017-01-23,CEO of Fluent, LLC,Schulke Ryan ,买入,150000普通股, $3.15
$Cogent(COGT)$ 内部交易: 2016-12-14,执行Chairman,Brauser Michael ,买入,1000普通股, $3.34
$Cogent(COGT)$ 内部交易: 2016-12-14,执行Chairman,Brauser Michael ,买入,500普通股, $3.20
$Cogent(COGT)$ 美东时间 2016-11-03 16:30 After Market Close:COGINT INC Earning Release . Wall St EPS Est ($):-0.11. 网页链接
$Cogent(COGT)$ SC TO-T/A [Amend] - Tender offer statement by Third Party Filed: 2010-10-27 AccNo: 0001104659-10-054045 Size: 122 KB 网页链接